HK118093A - 3-(n-methyl-n-alkylamino)-2-methoxymethyl-propanol derivatives - Google Patents

3-(n-methyl-n-alkylamino)-2-methoxymethyl-propanol derivatives

Info

Publication number
HK118093A
HK118093A HK1180/93A HK118093A HK118093A HK 118093 A HK118093 A HK 118093A HK 1180/93 A HK1180/93 A HK 1180/93A HK 118093 A HK118093 A HK 118093A HK 118093 A HK118093 A HK 118093A
Authority
HK
Hong Kong
Prior art keywords
methoxymethyl
alkylamino
methyl
propanol derivatives
propanol
Prior art date
Application number
HK1180/93A
Other languages
English (en)
Inventor
Pierre Braquet
Colette Broquet
Benedicte Vandamme
Paola Principe-Nicolas
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of HK118093A publication Critical patent/HK118093A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
HK1180/93A 1989-12-19 1993-11-04 3-(n-methyl-n-alkylamino)-2-methoxymethyl-propanol derivatives HK118093A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898928580A GB8928580D0 (en) 1989-12-19 1989-12-19 3-(n-methyl-n-alkylamino)-methoxymethyl-propanol phosphocholine derivatives

Publications (1)

Publication Number Publication Date
HK118093A true HK118093A (en) 1993-11-12

Family

ID=10668132

Family Applications (1)

Application Number Title Priority Date Filing Date
HK1180/93A HK118093A (en) 1989-12-19 1993-11-04 3-(n-methyl-n-alkylamino)-2-methoxymethyl-propanol derivatives

Country Status (32)

Country Link
US (1) US5118674A (no)
JP (1) JPH04208256A (no)
KR (1) KR910011759A (no)
AR (1) AR246742A1 (no)
AT (1) AT400333B (no)
AU (1) AU630056B2 (no)
BE (1) BE1004089A3 (no)
CA (1) CA2032224C (no)
CH (1) CH681624A5 (no)
DE (1) DE4040685A1 (no)
DK (1) DK171298B1 (no)
DZ (1) DZ1471A1 (no)
ES (1) ES2023607A6 (no)
FI (1) FI906162A (no)
FR (2) FR2656797B1 (no)
GB (2) GB8928580D0 (no)
GR (1) GR1000893B (no)
HK (1) HK118093A (no)
IE (1) IE65888B1 (no)
IN (1) IN173969B (no)
IT (1) IT1243412B (no)
LU (1) LU87853A1 (no)
MA (1) MA22013A1 (no)
MY (1) MY104781A (no)
NL (1) NL9002582A (no)
NO (1) NO177146C (no)
NZ (1) NZ236213A (no)
OA (1) OA09475A (no)
PT (1) PT96265B (no)
SE (1) SE469383B (no)
TN (1) TNSN90152A1 (no)
ZA (1) ZA909663B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
CA2171281C (en) 1993-09-09 1998-12-29 Romeo Rang Immunomodulating compositions from bile
KR19980703088A (ko) 1995-03-16 1998-09-05 라카일레 지, 필리페 신규의 침전탄산칼슘 안료를 포함하는 잉크젯 기록지
US20040101569A1 (en) * 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
DE19711758C2 (de) * 1997-03-21 2003-06-18 Degussa Verfahren zur Herstellung von 1,3-Dioxanverbindungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732263A1 (de) * 1977-07-16 1979-02-01 Schuler Gmbh L Vorrichtung zum herstellen einer sicke am umfang eines hohlzylinders
DE2820893C2 (de) * 1978-05-12 1986-02-20 A. Nattermann & Cie GmbH, 5000 Köln Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen
US4737518A (en) * 1984-04-03 1988-04-12 Takeda Chemical Industries, Ltd. Lipid derivatives, their production and use
WO1989007099A1 (en) * 1988-02-05 1989-08-10 Schering Corporation 2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use
JP2534893B2 (ja) * 1988-06-24 1996-09-18 日本ケミファ株式会社 新規なグリセリン誘導体およびその誘導体を含有する血小板凝集抑制剤
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
GR1000688B (el) * 1989-12-22 1992-10-08 Sod Conseils Rech Applic Μεθοδος παρασκευης παραγωγων γλυκερινης.

Also Published As

Publication number Publication date
AR246742A1 (es) 1994-09-30
ES2023607A6 (es) 1992-01-16
CH681624A5 (no) 1993-04-30
CA2032224C (en) 1996-12-10
GB8928580D0 (en) 1990-02-21
ATA259590A (de) 1995-04-15
IT9022438A1 (it) 1992-06-19
NO177146B (no) 1995-04-18
NL9002582A (nl) 1991-07-16
IN173969B (no) 1994-08-13
MA22013A1 (fr) 1991-07-01
FR2656797B1 (fr) 1992-09-18
DK299590A (da) 1991-06-20
BE1004089A3 (fr) 1992-09-22
AU630056B2 (en) 1992-10-15
AT400333B (de) 1995-12-27
FI906162A0 (fi) 1990-12-14
NO905373D0 (no) 1990-12-12
SE9004039L (sv) 1991-06-20
GB2239239A (en) 1991-06-26
IE904567A1 (en) 1991-06-19
NO905373L (no) 1991-06-20
OA09475A (fr) 1992-11-15
TNSN90152A1 (fr) 1991-03-05
AU6814290A (en) 1991-06-27
FI906162A (fi) 1991-06-20
ZA909663B (en) 1991-09-25
JPH04208256A (ja) 1992-07-29
KR910011759A (ko) 1991-08-07
IT1243412B (it) 1994-06-10
LU87853A1 (fr) 1991-05-07
DK299590D0 (da) 1990-12-18
GB2239239B (en) 1993-06-02
PT96265A (pt) 1991-09-30
IT9022438A0 (it) 1990-12-19
NO177146C (no) 1995-07-26
GR900100812A (en) 1992-05-12
SE9004039D0 (sv) 1990-12-18
CA2032224A1 (en) 1991-06-20
PT96265B (pt) 1998-06-30
FR2656307B1 (fr) 1992-09-18
SE469383B (sv) 1993-06-28
MY104781A (en) 1994-05-31
DE4040685A1 (de) 1991-06-20
FR2656307A1 (fr) 1991-06-28
US5118674A (en) 1992-06-02
IE65888B1 (en) 1995-11-29
GB9027421D0 (en) 1991-02-06
DZ1471A1 (fr) 2004-09-13
FR2656797A1 (fr) 1991-07-12
DK171298B1 (da) 1996-08-26
NZ236213A (en) 1993-03-26
GR1000893B (el) 1993-03-16

Similar Documents

Publication Publication Date Title
IL94047A0 (en) 3-substituted-2-oxindole derivatives
EP0430709A3 (en) Benzthiophen derivatives
EP0431421A3 (en) Heteroarylsubstituted pyridinylpyrimidin derivatives
GB2229723B (en) Thieno-triazolo-diazepine derivatives
GB2231330B (en) Thieno-triazolo-diazepine derivatives
EP0431424A3 (en) Pyridinylpyrimidin derivatives
GB2229724B (en) Thieno-triazolo-diazepine derivatives
EP0479951A4 (en) Bis-acyloxymethyl derivatives
GB2239239B (en) 3-(n-methyl-n-alkylamino)-2-methoxymethyl-propanol derivatives
EP0411636A3 (en) Piperidylthiocarbapenem derivatives
GB9015831D0 (en) Dihydropyrimidothiazine derivatives
GB8918275D0 (en) Fluoro-chloro-benzene derivatives
EP0438686A3 (en) Triazolylmethyl-cyclopropyl derivatives
GB2238310B (en) Selenophen derivatives
SG117593G (en) 3-(N-methyl-n-alkylamino)-2-methoxymethyl-propanol derivatives
ZA903608B (en) Substituted azacyclohexyl derivatives
GB9017950D0 (en) Fluoro-chloro-benzene derivatives
GB8916635D0 (en) Cardanolactam derivatives
LTIP336A (en) Substituted bicycloheptandione derivatives
ZA905740B (en) Substituted aminoalkoxybenzene derivatives
ZA909138B (en) Substituted pyrimidobenzimidazole derivatives
ZA904228B (en) Substituted aminoalkylbenzene derivatives
GB8928445D0 (en) Benzofuranyl-imidazole derivatives
GB8913442D0 (en) Fluoro-chloro-benzene derivatives
GB8913579D0 (en) Fluoro-chloro-benzene derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)